Prostaglandins are lipid signaling molecules your body makes at virtually every tissue site, and when their levels climb too high, the consequences range from amplified pain and fever to heavier menstrual periods, joint inflammation, and a tumor-friendly microenvironment. The overproduction usually traces back to ramped-up activity of an enzyme called cyclooxygenase-2 (COX-2), though reduced breakdown of prostaglandins plays a role too. What makes the picture tricky is that prostaglandins are not simply “bad” molecules you want to eliminate; many of them serve essential protective functions, and hammering them down indiscriminately creates its own set of problems.
How Prostaglandins Are Made and Cleared
Your cells build prostaglandins from arachidonic acid, a fatty acid embedded in cell membranes. The main assembly line runs through the cyclooxygenase (COX) enzyme system, which converts arachidonic acid into intermediate compounds that are then processed into specific prostaglandin types like PGE2, PGD2, PGF2α, and prostacyclin (PGI2).1PubMed Central. Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney Two versions of COX exist. COX-1 runs continuously and handles routine housekeeping: protecting the stomach lining, supporting kidney blood flow, and helping platelets function. COX-2 is the version that gets switched on during injury, infection, or stress, and it is primarily responsible for the prostaglandins that drive pain and inflammation.2PubMed. COX-1 and COX-2 in health and disease That said, COX-2 is not purely inflammatory; it also runs at low baseline levels in the brain, kidneys, and uterus, where its output serves normal physiological purposes.3PubMed Central. Different Chemical Structures and Physiological/Pathological Roles of Cyclooxygenases
On the clearance side, an enzyme called 15-hydroxyprostaglandin dehydrogenase (15-PGDH) breaks prostaglandins down once they have done their job. When 15-PGDH activity drops, prostaglandin levels rise even without extra COX activity. Animal studies show that knocking out 15-PGDH roughly doubles PGE2 concentrations in the lungs, colon, bone marrow, and liver.4Nature Reviews Drug Discovery. Inhibiting prostaglandin breakdown triggers tissue regeneration Reduced 15-PGDH expression has also been documented in lung tumors and other cancers, pairing with COX-2 overexpression to push prostaglandin levels higher from both directions at once.5PubMed Central. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer
What Drives Excess Production
The most common trigger is inflammation itself. When immune cells detect infection or tissue damage, signaling molecules like bacterial lipopolysaccharide (LPS) and pro-inflammatory cytokines ramp up COX-2 expression in macrophages. Certain cytokine combinations act synergistically, meaning two signals together produce far more COX-2 than either signal alone.6PubMed. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages This creates a feedback loop: tissue damage triggers inflammation, inflammation cranks up prostaglandin production, and the excess prostaglandins amplify swelling, redness, and pain at the site.
Chronic inflammatory conditions keep this loop running far longer than it should. In autoimmune diseases, persistent immune activation means COX-2 never fully switches off. Obesity is another driver, because adipose tissue is itself a source of pro-inflammatory cytokines that sustain COX-2 activity across many organs. Tumors exploit the same machinery: cancer cells frequently overexpress COX-2 while simultaneously losing 15-PGDH, creating a local environment flooded with prostaglandins that promote cell survival and growth.
Pain and Fever
If you have ever felt the throbbing ache of a sprained ankle or the full-body soreness during the flu, prostaglandins were central to the experience. PGE2 sensitizes nerve endings at the site of injury, lowering the threshold at which pain-sensing neurons fire. It does this by acting on ion channels in nociceptive nerve fibers, making them respond to stimuli that would normally be too mild to register as painful.7PubMed Central. The action of prostaglandins on ion channels This sensitization happens both at the injury site (peripheral sensitization) and in the spinal cord (central sensitization), which is why a badly inflamed area can feel painful even to light touch. Research has identified the Nav1.8 sodium channel as a key mediator of PGE2-driven nerve activation, co-localizing with PGE2 receptors on pain-sensing axons.8Scientific Reports. Prostaglandin E2 depolarises sensory axons in vitro in an ANO1 and Nav1.8 dependent manner
Fever works through a related but distinct pathway. PGE2 produced during infection acts on EP3 receptors in the hypothalamus, the brain region that sets your body’s temperature set-point. When PGE2 binds those receptors, the thermostat effectively gets turned up, triggering the shivering, vasoconstriction, and heat-seeking behavior you experience as a fever.9PubMed Central. Prostaglandin E2 that triggers fever is synthesized through an endocannabinoid-dependent pathway This is why NSAIDs bring fevers down: by blocking COX-2, they cut the PGE2 supply to the hypothalamus.
Gynecological Effects
Prostaglandins have an outsized influence on reproductive health, and excess levels are implicated in two conditions that affect millions of women: endometriosis and heavy menstrual bleeding.
In endometriosis, tissue resembling the uterine lining grows outside the uterus, often on the ovaries, fallopian tubes, or pelvic lining. PGE2 concentrations in the peritoneal fluid of women with endometriosis are measurably elevated, and this surplus PGE2 plays an active role in the survival and growth of lesions.10PubMed Central. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis The lesion tissue itself overexpresses COX enzymes and prostaglandin receptors (particularly EP2 and EP4), essentially fueling its own prostaglandin supply.11Scientific Reports. EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis Receptor and transporter expression is abnormally high in ectopic endometrial tissue, regardless of disease stage.12PubMed Central. Abnormal Expression of Prostaglandins E2 and F2 α Receptors and Transporters in Patients with Endometriosis The pain of endometriosis likely involves both peripheral and central sensitization pathways driven by PGE2, which is part of why standard painkillers often provide only incomplete relief.
Heavy menstrual bleeding (menorrhagia) involves a different prostaglandin, prostacyclin (PGI2). The endometrium of women with excessive menstrual bleeding produces more prostacyclin than normal, and since prostacyclin inhibits platelet clumping and dilates blood vessels, this excess prolongs and increases flow.13PubMed. A role for prostacyclin (PGi2) in excessive menstrual bleeding The connection is well enough established that prostaglandin synthesis inhibitors (NSAIDs like mefenamic acid and naproxen) are a standard first-line treatment for heavy periods, working specifically by reducing uterine prostacyclin release.14PubMed. Prostacyclin and thromboxane in gynecology and obstetrics
The Prostaglandin-Cancer Connection
Elevated prostaglandins, particularly PGE2, create a microenvironment that favors tumor development and progression. COX-2 overexpression is a common feature of colorectal, lung, breast, and other cancers, and the prostaglandins it generates promote cell proliferation, suppress immune surveillance against tumors, and stimulate new blood vessel growth to feed growing masses.15PubMed Central. Pro-inflammatory prostaglandins and progression of colorectal cancer This relationship prompted clinical trials of COX-2 inhibitors for cancer prevention, particularly in colorectal cancer. The results have been genuinely interesting but also complicated: NSAIDs do appear to reduce colorectal cancer risk, yet their anticancer effects may not depend entirely on COX-2 inhibition. Research points to additional targets beyond the cyclooxygenase pathway that NSAIDs affect.16PubMed Central. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase The cardiovascular risks of long-term COX-2 inhibitor use, as demonstrated by the rofecoxib (Vioxx) withdrawal in 2004, have tempered enthusiasm for this approach as a preventive strategy.
Gut Health and a Paradox
The gastrointestinal tract highlights one of the core contradictions of prostaglandin biology. On one hand, prostaglandins are clearly elevated in inflammatory bowel disease (IBD), and different prostaglandin types and their receptors display both pro-inflammatory and anti-inflammatory properties in the gut.17PubMed. Prostaglandins and Inflammatory Bowel Disease: From Mechanism to Clinic On the other hand, COX-2-derived prostaglandins are crucial for healing mucosal injury, defending against bacterial invasion, and dampening the gut immune response. Suppressing COX-2 when the gut is already inflamed and ulcerated has been shown in experimental models to impair healing and make the damage worse.18PubMed. Prostaglandin biology in inflammatory bowel disease
This is why people with IBD are often cautioned against regular NSAID use: the same drugs that help with joint pain or a headache can trigger flares by stripping the gut of the prostaglandins it needs to protect and repair itself. It is also why researchers are pursuing more selective approaches that can target specific prostaglandin receptors implicated in inflammation while leaving the protective pathways intact.
Prostaglandins and Sleep
Not all prostaglandin excess is harmful. Prostaglandin D2 (PGD2) is recognized as the most potent naturally occurring sleep-promoting substance in the body.19PubMed. Prostaglandin D2 and sleep/wake regulation PGD2 is produced in the membranes surrounding the brain and secreted into the cerebrospinal fluid, where it acts as something closer to a hormone than a typical neurotransmitter. It binds to receptors on the underside of the forebrain, triggering adenosine release, which in turn activates sleep-promoting neurons and inhibits the brain’s histamine-based wakefulness system.20PubMed. Prostaglandin D2 and sleep regulation PGD2 concentrations in cerebrospinal fluid rise and fall with the sleep-wake cycle, increasing as sleep pressure builds.
The connection to adenosine explains something many people already know intuitively: caffeine keeps you awake. Caffeine blocks adenosine A2A receptors, the same receptors that PGD2-triggered adenosine uses to flip the switch toward sleep. In animal studies, blocking any link in the PGD2-adenosine chain suppresses both non-rapid eye movement and rapid eye movement sleep.19PubMed. Prostaglandin D2 and sleep/wake regulation This positions PGD2 as essential for maintaining normal sleep architecture, and raises interesting questions about whether systemic prostaglandin suppression through chronic NSAID use might subtly affect sleep quality, though that connection has not been firmly established in clinical trials.
Prostaglandins in the Eye
One of the more unexpected chapters in prostaglandin science involves glaucoma treatment. Prostaglandin analogues that mimic PGF2α are the front-line medications for glaucoma, lowering the intraocular pressure that damages the optic nerve.21PubMed. Prostaglandins in the eye: Function, expression, and roles in glaucoma Drugs like latanoprost, bimatoprost, and travoprost all work by enhancing the drainage of fluid from the eye through the FP receptor. The irony is that while most prostaglandin-related medicine focuses on reducing prostaglandin activity, ophthalmology actively harnesses it. Side effects of these prostaglandin eye drops include darkening of the iris, lengthening of eyelashes, and occasional redness, all consequences of sustained local prostaglandin receptor activation. The eyelash-lengthening effect was so noticeable that bimatoprost was eventually repurposed as a cosmetic product for eyelash growth.
Managing Excess Prostaglandins
The workhorse approach has been NSAIDs for decades. Ibuprofen, naproxen, aspirin, and others all reduce prostaglandin output by inhibiting COX enzymes. Traditional NSAIDs block both COX-1 and COX-2, which is why they work against pain and inflammation but also cause stomach irritation and increase bleeding risk: you are knocking out the protective prostaglandins alongside the problematic ones. Selective COX-2 inhibitors (like celecoxib) were designed to spare COX-1 and reduce gastrointestinal side effects, but the cardiovascular risks that emerged with some drugs in this class showed that selectivity is not a free lunch.
The field is now moving toward even more targeted strategies. One promising approach is inhibiting microsomal prostaglandin E synthase-1 (mPGES-1), the enzyme that sits downstream of COX-2 and specifically produces PGE2. Blocking mPGES-1 should reduce the inflammatory PGE2 output without affecting other prostaglandin types, potentially avoiding the cardiovascular and gastrointestinal problems of broader COX inhibition. Two mPGES-1 inhibitors are currently in clinical trials.22PubMed Central. Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases Other strategies in development include subtype-selective EP receptor modulators that block specific prostaglandin receptors involved in disease while leaving the beneficial ones active, and targeting downstream signaling pathways that prostaglandins activate inside cells.23PubMed Central. The dual pathological roles and targeted therapy of PGE2: from receptor signaling networks to disease microenvironment modulation
Dietary Influence Through Omega-3 Fats
The type of fat you eat changes which prostaglandins your body makes. Arachidonic acid, the starting material for the most inflammatory prostaglandins (the “2-series,” including PGE2), comes from omega-6 fatty acids abundant in vegetable oils, poultry, and eggs. Omega-3 fatty acids from fish, flaxseed, and walnuts compete for the same enzymatic pathways but produce a different family of prostaglandins (the “3-series,” like PGE3) that are less inflammatory. Dietary omega-3 supplementation reduces concentrations of 2-series prostaglandins while increasing 3-series output.24PubMed Central. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion This does not eliminate inflammation, but it tilts the balance toward a less aggressive inflammatory profile.
The practical takeaway is not that omega-6 fats are villains. Your body needs them for normal prostaglandin function. The issue is the ratio. Modern Western diets tend to be heavily skewed toward omega-6 intake, and shifting some of that toward omega-3 sources can meaningfully change the prostaglandin landscape. This is part of the rationale behind recommendations to eat fatty fish twice a week or consider fish oil supplements, though the magnitude of benefit depends on where your diet starts and how large the shift is.
The Risks of Over-Suppression
Because prostaglandins perform genuine protective duties, blocking them too aggressively carries real consequences. The kidneys are especially vulnerable. Prostaglandins PGE2 and PGI2 help maintain blood flow to the kidneys and regulate salt and water balance. NSAIDs, by blocking these prostaglandins, can trigger acute kidney injury, elevated potassium levels, high blood pressure, and fluid retention.25Heart Failure Clinics. Management of Kidney Associated Clinical Problems Renal Consequences of Prostaglandin Inhibition in Heart Failure Medical literature links NSAID use to acute kidney injury, a specific type of kidney inflammation, and with prolonged use, chronic kidney disease.26PubMed Central. Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature The two COX isoforms appear to have opposing roles in the kidney: inhibiting COX-1 tends to increase sodium excretion and lower blood pressure, while inhibiting COX-2 promotes sodium retention and raises blood pressure. Broad-spectrum NSAIDs hit both, creating a mixed and often unfavorable renal profile, particularly in people who already have heart failure, chronic kidney disease, or are taking certain blood pressure medications.
The stomach is the other classic vulnerability. COX-1-derived prostaglandins maintain the mucus barrier that protects the stomach lining from its own acid. Strip those prostaglandins away with chronic NSAID use, and ulcers and GI bleeding become real risks. This is why long-term NSAID users are often prescribed a proton pump inhibitor alongside the anti-inflammatory.
Prostaglandins and the Resolution of Inflammation
One of the more counterintuitive findings in recent prostaglandin research is that the same molecules that initiate inflammation also help resolve it. The early phase of an inflammatory response is dominated by prostaglandins and leukotrienes, which recruit immune cells and amplify the alarm signal. But as the response progresses, prostaglandins contribute to a “lipid-mediator class switch,” promoting the production of specialized pro-resolving mediators like lipoxins and resolvins that actively shut inflammation down.27PubMed Central. Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch If you suppress prostaglandins too early or too completely, you may prevent inflammation from starting, but you may also prevent it from resolving properly once it has begun. This dual role helps explain why chronic NSAID use does not always produce the clean anti-inflammatory outcome people expect, and why some inflammatory conditions seem to stall in a state of unresolved low-grade inflammation rather than healing cleanly.
Exercise and Prostaglandin Spikes
Physical activity transiently increases certain prostaglandin-related compounds. A pilot study of professional volleyball players found that a training period significantly elevated 8-iso-prostaglandin F2α, a marker of oxidative stress and lipid damage, alongside increased expression of an enzyme involved in lipid oxidative processing.28PubMed Central. 8-Iso-Prostaglandin F2α and Lipoxygenase Gene Expression as Candidate Molecular Markers of Training Adaptation in Professional Volleyball Players: A Pilot Study These increases are not necessarily harmful. They likely reflect normal adaptive signaling as the body responds to physical stress, and similar transient inflammatory responses to exercise are believed to drive the long-term anti-inflammatory benefits of regular training. The concern would arise only if such elevations became chronic without adequate recovery, as might happen with overtraining or in individuals with pre-existing inflammatory conditions who exercise intensely without appropriate management.
Taking NSAIDs before or after exercise to blunt soreness may interfere with this adaptive signaling. Some sports medicine researchers have raised concerns that routine prophylactic NSAID use among athletes might impair tissue repair and training adaptation, though the evidence on this is still mixed. The practical point for most people is that post-exercise prostaglandin spikes are a feature, not a bug, and reaching for ibuprofen after every workout may not be doing your recovery any favors.